期刊文献+

解放军第一八〇医院2014―2016年神经营养类辅助用药的应用分析 被引量:8

Analysis of the utilization of neurotrophic adjuvant drugs in our hospital during 2014―2016
原文传递
导出
摘要 目的:为临床合理使用神经营养类辅助用药提供参考。方法:应用医院信息系统(HIS),提取、统计和分析解放军第一八〇医院2014—2016年神经营养类辅助用药的销售金额、用药频度(DDDs)、日均费用(DDC)、排序比(B/A)以及各科室使用情况。结果:2016年神经营养类辅助用药销售总金额为2 260.28万元,较2015年的2 840.96万元明显下降。而2014—2016年DDDs总量由121 588.58上升至145 062.08,且单唾液酸四己糖神经节苷脂钠注射剂、鼠神经生长因子注射剂(18μg)、前列地尔注射液(10μg)、小牛血去蛋白提取物冻干粉、马来酸桂哌齐特注射液(320 mg)和脑苷肌肽注射液6种神经营养类辅助用药的金额比近3年总体仍呈上升趋势。除脑蛋白水解物冻干粉和奥拉西坦粉针剂外,其他药品连续3年的B/A均在0.5~1.5,同步性较好。2016年脑苷肌肽注射液DDC排名升至第1位,该药连续3年使用率排名第1位的科室是神经内科,2016年该药销售金额比排名前3位的科室分别为骨科二区、神经内科和骨科一区。结论:结合各科室的疾病谱以及各种药品的特点,神经营养类辅助用药的使用总体较为合理,但仍需加强监管,规范临床使用,规避用药风险。 Objective: To provide reference for rational use of neurotrophic adjuvant drugs in clinic. Methods: The sales, DDDs DDC, sorting ratio (B/A), and departments using neurotrophic adjuvant drugs in our hospital from 2014 to 20/6 were extracted from the hospital information system (HIS), and statistical analysis was made. Results: In 2016, the total sales of neurotrophic adjuvant drugs was 22 602 800 yuan, which was obviously lower than that of 28 409 600 yuan in 2015. However, the total DDDs increased from 121 588.58 to 145 062.08 during 2014--2016. Overall, the amount ratios of monosialotetrahexosylganglioside sodium injection, mouse nerve factor injection (18 pg), alprostadil injection (10μg), deproteinized calf blood extractives frozen powder tbr injection, cinepazide malcate injection (320 rag) and cattle encephalon glycoside and ignotin injection were still rising in the last 3 years, in addition to cerebroprotein hydrolysate frozen powder for injection and oxiracetam frozen powder for injection, the B/A of all the other drugs ranged from 0.5 to 1.5 in the last 3 years and the synchronization was better. In 2016, the DDCs of cattle encephalon glycoside and ignotin injection rose to the first place and its utilization rate in the department of neurology ranked the first for 3 years. The second department of orthopedics, the department of neurology and the first department of orthopedics were the top three departments for the amount ratio of cattle enccphahm glycoside and ignotin injection in 2016. Conclusion: Based on the spectrum of diseases and the characteristics of drugs, the application of neurotrophic adjuvant drugs in our hospital is rational on the whole, meanwhile, the hospital should strengthen supervision and standardize medication behaviors so as to avoid the risk of irrational medication.
出处 《临床药物治疗杂志》 2017年第10期40-45,共6页 Clinical Medication Journal
关键词 神经营养 辅助用药 脑苷肌肽注射液 用药分析 neurotrophic adjuvant drugs cattle encephalon glycoside and ignotin injection: analysis of drug use
  • 相关文献

参考文献4

二级参考文献33

  • 1邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1426
  • 2王秀兰,张淑文.临床药物治疗学[M].第8版.北京:人民卫生出版社,2007:18-34.
  • 3中国药典临床用药须知[S].化学药和生物制品卷.2005年版.1-2,17.
  • 4陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 5杨其莲,韩冰,祁红.2007-2010年上海市闵行区中心医院免疫增强剂使用分析.蚌埠医学院学报,2012,37(1):76-80.
  • 6刘庭芳,刘勇.中国医院评审评价追踪方法学操作手册(试行本)[M].北京:人民卫生出版社,2012:11.
  • 7王南卜,曹梦涵.脑源性神经营养药物的临床应用[J].中国药物经济学,2012(4):102-104.
  • 8美国国立医学图书馆.Adjuvants,Pharmaceutic[EB/OL].http://www.ncbi.him.nih.gov/mesh/68000277.2011/2014—12.
  • 9梅清华,兰树敏,范翠琴,等.辅助治疗药物范围界定探讨[C].西安:中国药学会第四届临床药学实践案例分享与合理用药学术研讨会论文集,2011.254-255.
  • 10李大魁,金有豫,汤光,等.马丁代尔大药典[M].第35版.北京:化学工业出版社,2008.1316-1546.

共引文献169

同被引文献78

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部